{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:56:06Z","timestamp":1767992166358,"version":"3.49.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.semnephrol.2006.09.009","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T13:22:07Z","timestamp":1222003327000},"page":"69-80","source":"Crossref","is-referenced-by-count":50,"title":["Complement in Lupus Nephritis: The Good, the Bad, and the Unknown"],"prefix":"10.1016","volume":"27","author":[{"given":"Lihua","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Quigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2006.09.009_bib1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Advances in immunology: complement","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib2","series-title":"Fundamental immunology","first-page":"917","article-title":"The complement system","author":"Liszewski","year":"1993"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib3","series-title":"Principles and practices of clinical immunology","first-page":"211","article-title":"Complement","author":"Holers","year":"2001"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1074-7613(00)80419-7","article-title":"cDNA cloning and primary structure analysis of C1qR(P), the human C1q\/MBL\/SPA receptor that mediates enhanced phagocytosis in vitro","volume":"6","author":"Nepomuceno","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib5","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.4049\/jimmunol.168.10.5222","article-title":"Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q","volume":"168","author":"McGreal","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.molimm.2005.07.030","article-title":"Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR","volume":"43","author":"Vegh","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI110529","article-title":"Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases","volume":"69","author":"Kazatchkine","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib8","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.175.3.1947","article-title":"Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis","volume":"175","author":"Bao","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib9","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.4049\/jimmunol.173.6.4190","article-title":"Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells","volume":"173","author":"Braun","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.iy.04.040186.002443","article-title":"The membrane attack complex of complement","volume":"4","author":"M\u00fcller-Eberhard","year":"1986","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00919144","article-title":"Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system","volume":"3","author":"Densen","year":"1983","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/mp.55.3.145","article-title":"Paroxysmal nocturnal haemoglobinuria: nature\u2019s gene therapy?","volume":"55","author":"Johnson","year":"2002","journal-title":"Mol Pathol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib13","first-page":"115","article-title":"Effects of the membrane attack complex of complement on nucleated cells","volume":"178","author":"Morgan","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/IR:31:1:37","article-title":"The role of C5b-9 terminal complement complex in activation of the cell cycle and transcription","volume":"31","author":"Fosbrink","year":"2005","journal-title":"Immunol Res"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molimm.2004.04.007","article-title":"Cell signals transduced by complement","volume":"41","author":"Bohana-Kashtan","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1084\/jem.167.4.1271","article-title":"Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1","volume":"167","author":"Carroll","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.169.2.597","article-title":"Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3\u2032 end of the C3b\/C4b receptor gene","volume":"169","author":"Bora","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0065-2776(08)60697-5","article-title":"The regulators of complement activation (RCA) gene cluster","volume":"45","author":"Hourcade","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib19","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.4049\/jimmunol.134.6.4048","article-title":"p65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor","volume":"134","author":"Wong","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4049\/jimmunol.142.2.582","article-title":"The murine complement receptor gene family. I.","volume":"142","author":"Paul","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib21","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.162.4.2281","article-title":"The beta-glucan-binding lectin site of mouse CR3 (CD11b\/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells","volume":"162","author":"Xia","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib22","series-title":"Regulation in the activation pathways","first-page":"41","author":"Morgan","year":"1999"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib23","series-title":"Complement regulatory proteins","first-page":"137","article-title":"Regulation in the terminal pathway","author":"Morgan","year":"2005"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780280810","article-title":"The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus","volume":"28","author":"Valentijn","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10408368609110272","article-title":"Complement in the pathophysiology and diagnosis of human diseases","volume":"24","author":"Dalmasso","year":"1986","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/art.1780390716","article-title":"Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity","volume":"39","author":"Manzi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ki.1989.83","article-title":"Physiological and pathological aspects of circulating immune complexes","volume":"35","author":"Schifferli","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01837367","article-title":"Complement deficiency and immune complex disease","volume":"15","author":"Davies","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10157-005-0357-8","article-title":"Mechanisms of immune-deposit formation and the mediation of immune renal injury","volume":"9","author":"Nangaku","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0272-6386(12)80488-4","article-title":"The clearance of immune complexes from the circulation of man and other primates","volume":"27","author":"Hebert","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198608213150805","article-title":"The role of complement and its receptor in the elimination of immune complexes","volume":"315","author":"Schifferli","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1523-1755.1998.00723.x","article-title":"Immune complex glomerulonephritis in C4- and C3-deficient mice","volume":"53","author":"Quigg","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib33","doi-asserted-by":"crossref","first-page":"32129","DOI":"10.1074\/jbc.M101299200","article-title":"A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor","volume":"276","author":"Alexander","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib34","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.135.3.2005","article-title":"Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and\/or complement activation","volume":"135","author":"Ross","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib35","first-page":"300","article-title":"C3b receptor (CR1) expression of the polymorphonuclear leukocytes from patients with systemic lupus erythematosus","volume":"67","author":"Fyfe","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0162-3109(99)00018-1","article-title":"Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance","volume":"42","author":"Navratil","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1191\/0961203303lu329oa","article-title":"Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus","volume":"12","author":"Racila","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib39","first-page":"667","article-title":"High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients","volume":"19","author":"Horvath","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00281-005-0007-y","article-title":"Antibodies against C1q in patients with systemic lupus erythematosus","volume":"27","author":"Trendelenburg","year":"2005","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","article-title":"Systemic lupus erythematosus, complement deficiency, and apoptosis","volume":"76","author":"Pickering","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.192.3.359","article-title":"A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo","volume":"192","author":"Taylor","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib44","series-title":"Dubois\u2019 lupus erythematosus","first-page":"339","article-title":"Animal models of systemic lupus erythematosus","author":"Hahn","year":"2001"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1995.tb00065.x","article-title":"Genetic contributions to lupus-like disease in (NZB x NZW) F1 mice","volume":"144","author":"Drake","year":"1995","journal-title":"Immunol Rev"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0090-1229(91)90102-G","article-title":"Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16\/6 Id+) and for mouse tuberculosis antibody TB\/68 (16\/6 Id+)","volume":"60","author":"Blank","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib48","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.4049\/jimmunol.155.6.3205","article-title":"SLE-like autoantibodies and Sjogren\u2019s syndrome-like lymphoproliferation in TGF-beta knockout mice","volume":"155","author":"Dang","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib49","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.4049\/jimmunol.168.5.2538","article-title":"C1q deficiency and autoimmunity: the effects of genetic background on disease expression","volume":"168","author":"Mitchell","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.iy.07.040189.000343","article-title":"Decay-accelerating factor: biochemistry, molecular biology, and function","volume":"7","author":"Lublin","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1989.167","article-title":"Localization of decay accelerating factor in normal and diseased kidneys","volume":"36","author":"Cosio","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib52","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1046\/j.1523-1755.2002.t01-1-00652.x","article-title":"Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes","volume":"62","author":"Bao","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.142.3.877","article-title":"Decay accelerating factor regulates complement activation on glomerular epithelial cells","volume":"142","author":"Quigg","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib54","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.167.5.2791","article-title":"Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis","volume":"167","author":"Sogabe","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1523-1755.1998.00961.x","article-title":"Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney","volume":"54","author":"Abe","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120300678828154","article-title":"Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis","volume":"9","author":"Arora","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0002-9440(10)64268-X","article-title":"Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL\/lpr mice","volume":"161","author":"Miwa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2567.1999.00859.x","article-title":"Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55)","volume":"98","author":"Qian","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib59","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","volume":"201","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1084\/jem.181.1.151","article-title":"Mouse complement regulatory protein Crry\/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein","volume":"181","author":"Kim","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib61","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.151.8.4295","article-title":"Mouse Crry\/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF","volume":"151","author":"Li","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1681\/ASN.V62234","article-title":"Role of a complement regulatory protein in rat mesangial glomerulonephritis","volume":"6","author":"Nishikage","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib63","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.180.5.1619","article-title":"In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats","volume":"180","author":"Matsuo","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib64","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ki.1995.471","article-title":"Role of a rat membrane inhibitor of complement in anti-basement membrane antibody-induced renal injury","volume":"48","author":"Hatanaka","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib65","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.162.9.5477","article-title":"Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide","volume":"162","author":"Mizuno","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.287.5452.498","article-title":"A critical role for murine complement regulator Crry in fetomaternal tolerance","volume":"287","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib67","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.V5111888","article-title":"The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis","volume":"5","author":"Couser","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib68","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1084\/jem.188.7.1321","article-title":"Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury","volume":"188","author":"Quigg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib69","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.4049\/jimmunol.168.7.3601","article-title":"Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL\/lpr mice","volume":"168","author":"Bao","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib70","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.160.9.4553","article-title":"Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor","volume":"160","author":"Quigg","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib71","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.ASN.0000051597.27127.A1","article-title":"Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL\/lpr mice","volume":"14","author":"Bao","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib72","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1097\/01.ASN.0000089831.96794.0B","article-title":"Excessive matrix accumulation in the kidneys of MRL\/lpr lupus mice Is dependent on complement activation","volume":"14","author":"Bao","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib73","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.145.9.2974","article-title":"A molecular and immunochemical characterization of mouse CR2","volume":"145","author":"Molina","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/art.1780290606","article-title":"Decreased expression of the C3b\/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus","volume":"29","author":"Wilson","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib75","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4049\/jimmunol.159.3.1557","article-title":"Mouse complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21)","volume":"159","author":"Takahashi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib76","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.168.3.1036","article-title":"Complement C4 is protective for lupus disease independent of C3","volume":"168","author":"Einav","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib77","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1074-7613(00)80669-X","article-title":"A critical role for complement in maintenance of self-tolerance","volume":"9","author":"Prodeus","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib78","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1006\/clim.1999.4813","article-title":"A protective role for innate immunity in autoimmune disease","volume":"95","author":"Carroll","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/rheumatology\/39.2.133","article-title":"Links between complement abnormalities and systemic lupus erythematosus","volume":"39","author":"Pickering","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08916930410001685063","article-title":"CR1\/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL\/lpr model of SLE","volume":"37","author":"Boackle","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib82","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI117751","article-title":"Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency","volume":"95","author":"Hogasen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2001-15248","article-title":"Complement factor H: physiology and pathophysiology","volume":"27","author":"Zipfel","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib84","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib85","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1523-1755.2004.00371.x","article-title":"Effects of complement factor D deficiency on the renal disease of MRL\/lpr mice","volume":"65","author":"Elliott","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib86","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1073\/pnas.93.16.8563","article-title":"Amelioration of lupus-like autoimmune disease in NZB\/W F1 mice after treatment with a blocking monoclonal antibody specific for complement component C5","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib87","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/eji.200526327","article-title":"C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist","volume":"35","author":"Bao","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib88","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1681\/ASN.2005040373","article-title":"C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice","volume":"16","author":"Wenderfer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib89","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.4049\/jimmunol.166.10.6444","article-title":"Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL\/lpr mice","volume":"166","author":"Sekine","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2567.1999.00805.x","article-title":"Altered distribution of intraglomerular immune complexes in C3-deficient mice","volume":"97","author":"Sheerin","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib91","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","article-title":"Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis","volume":"279","author":"Clynes","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/art.10813","article-title":"Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL\/lpr mice","volume":"48","author":"Matsumoto","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib93","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1084\/jem.140.1.126","article-title":"Role of complement in induction of antibody production in vivo","volume":"140","author":"Pepys","year":"1974","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.immunol.16.1.545","article-title":"The role of complement and complement receptors in induction and regulation of immunity","volume":"16","author":"Carroll","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib95","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI25208","article-title":"Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection","volume":"115","author":"Atkinson","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib96","doi-asserted-by":"crossref","first-page":"27290","DOI":"10.1074\/jbc.M100436200","article-title":"Targeting of functional antibody-decay-accelerating factor fusion proteins to a cell surface","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI4607","article-title":"Targeting of functional antibody-CD59 fusion proteins to a cell surface","volume":"103","author":"Zhang","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib98","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.4049\/jimmunol.174.9.5750","article-title":"Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9","volume":"174","author":"He","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib99","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI17348","article-title":"Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation","volume":"111","author":"Song","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib100","first-page":"179","article-title":"Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis","volume":"142","author":"Schulze","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib101","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1097\/00003246-200009000-00004","article-title":"Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome","volume":"28","author":"Zimmerman","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib102","doi-asserted-by":"crossref","first-page":"II274","DOI":"10.1161\/01.CIR.0000138315.99788.eb","article-title":"Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass","volume":"110","author":"Lazar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib103","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jtcvs.2004.06.048","article-title":"A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings","volume":"129","author":"Keshavjee","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib104","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.athoracsur.2003.08.054","article-title":"Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass","volume":"77","author":"Shernan","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib105","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.CIR.100.25.2499","article-title":"Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass","volume":"100","author":"Fitch","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib106","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib107","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2005-02-0564","article-title":"Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Hill","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2006.09.009_bib108","doi-asserted-by":"crossref","first-page":"F660","DOI":"10.1152\/ajprenal.00437.2004","article-title":"Experimental membranous nephropathy redux","volume":"289","author":"Cybulsky","year":"2005","journal-title":"Am J Physiol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929506001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929506001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:24:20Z","timestamp":1684545860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929506001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0270929506001197"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2006.09.009","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}